Morning Briefing
Summaries of health policy coverage from major news organizations
Researchers' Efforts To Develop HIV Treatment Examined
Forbes recently examined the challenges Merck researcher Daria Hazuda encountered while developing the HIV treatment Isentress, which " was Merck's fastest growing medicine last quarter."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
